Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Eva Martins"'
Autor:
Eva Martins, Pedro Castro, Alessandra B. Ribeiro, Carla F. Pereira, Francisca Casanova, Rui Vilarinho, Joaquim Moreira, Óscar L. Ramos
Publikováno v:
Cosmetics, Vol 11, Iss 5, p 150 (2024)
The increasing demand for effective hair care products has highlighted the necessity for rigorous claims substantiation methods, particularly for products that target specific hair types. This is essential because the effectiveness of a product can v
Externí odkaz:
https://doaj.org/article/851511002fa34c0db37496365fe2dc5f
Autor:
Miguel S. Rocha, Catarina F. Marques, Ana C. Carvalho, Eva Martins, Alexander Ereskovsky, Rui L. Reis, Tiago H. Silva
Publikováno v:
Marine Drugs, Vol 22, Iss 2, p 55 (2024)
Chondrosia reniformis is a collagen-rich marine sponge that is considered a sustainable and viable option for producing an alternative to mammalian-origin collagens. However, there is a lack of knowledge regarding the properties of collagen isolated
Externí odkaz:
https://doaj.org/article/39e25bcc0ca6425a86b1d1abe5050d14
Autor:
Francisca Casanova, Carla F. Pereira, Alessandra B. Ribeiro, Pedro M. Castro, Ricardo Freixo, Eva Martins, Diana Tavares-Valente, João C. Fernandes, Manuela E. Pintado, Óscar L. Ramos
Publikováno v:
Pharmaceuticals, Vol 16, Iss 12, p 1737 (2023)
Curcumin is a natural phenolic compound with important biological functions. Despite its demonstrated efficacy in vitro, curcumin biological activities in vivo are dependent on its bioaccessibility and bioavailability, which have been highlighted as
Externí odkaz:
https://doaj.org/article/bfdded2ea90340498cc9e6228ab71716
Publikováno v:
Polymers, Vol 15, Iss 7, p 1674 (2023)
Marine-origin gelatin has been increasingly used as a safe alternative to bovine and porcine ones due to their structural similarity, avoiding the health-related problems and sociocultural concerns associated with using mammalian-origin materials. An
Externí odkaz:
https://doaj.org/article/dc7930e1f62c43e183e4c7ba4bf8ef57
Publikováno v:
Marine Drugs, Vol 21, Iss 2, p 57 (2023)
The industrial processing of fish for food purposes also generates a considerable number of by-products such as viscera, bones, scales, and skin. From a value-added perspective, fish by-products can act also as raw materials, especially because of th
Externí odkaz:
https://doaj.org/article/ae97ed62f3ca4389b517cb5c45b1406a
Publikováno v:
Marine Drugs, Vol 20, Iss 11, p 718 (2022)
Ocean resources are a priceless repository of unique species and bioactive compounds with denouement properties that can be used in the fabrication of advanced biomaterials as new templates for supporting the cell culture envisaging tissue engineerin
Externí odkaz:
https://doaj.org/article/4240a34b73644aec982c96a4d9e82049
Publikováno v:
Applied Sciences, Vol 12, Iss 21, p 11282 (2022)
Collagen is a ubiquitous protein present in the extracellular matrix of all major metazoan animals, with approximately 28 different human collagen types described in the literature, each with unique physicochemical properties. Collagens found broad a
Externí odkaz:
https://doaj.org/article/3d7819b33ce642e3a8338f5c665d8cba
Publikováno v:
Frontiers in Marine Science, Vol 7 (2021)
Sponges occur ubiquitously in the marine realm and in some deep-sea areas they dominate the benthic communities forming complex biogenic habitats – sponge grounds, aggregations, gardens and reefs. However, deep-sea sponges and sponge-grounds are st
Externí odkaz:
https://doaj.org/article/3f84dcf1c1244f818b5437f01ffe4419
Publikováno v:
Marine Drugs, Vol 18, Iss 12, p 617 (2020)
With the worldwide increase of fisheries, fish wastes have had a similar increase, alternatively they can be seen as a source of novel substances for the improvement of society’s wellbeing. Elasmobranchs are a subclass fished in high amounts, with
Externí odkaz:
https://doaj.org/article/cb12dda5e118451baddeac20b2ef5b1f
Autor:
Miguel Pinto, Carlos Fernandes, Eva Martins, Renata Silva, Sofia Benfeito, Fernando Cagide, Ricardo F. Mendes, Filipe A. Almeida Paz, Jorge Garrido, Fernando Remião, Fernanda Borges
Publikováno v:
Pharmaceutics, Vol 11, Iss 7, p 331 (2019)
The current pharmacological treatments for Parkinson’s disease only offer symptomatic relief to the patients and are based on the administration of levodopa and catechol-O-methyltransferase or monoamine oxidase-B inhibitors (IMAO-B). Since the majo
Externí odkaz:
https://doaj.org/article/6e3e31cd8ee44145b386e0ba45f1a421